Market Snapshot
  • U.S.
  • Europe
  • Asia
Ticker Volume Price Price Delta
DJIA 12,580.70 +125.86 1.01%
S&P 500 1,332.42 +14.60 1.11%
Nasdaq 2,870.99 +33.46 1.18%
Ticker Volume Price Price Delta
STOXX 50 2,136.84 -23.47 -1.09%
FTSE 100 5,318.81 -72.33 -1.34%
DAX 6,337.62 -59.22 -0.93%
Ticker Volume Price Price Delta
Nikkei 8,633.19 -23.89 -0.28%
TOPIX 723.62 -3.41 -0.47%
Hang Seng 18,690.20 -365.24 -1.92%
Gold 1,548.70 -0.15%
EUR-USD 1.2440 -0.5008%
Nasdaq 2,870.99 +1.18%
DJIA 12,580.70 +1.01%
S&P 500 1,332.42 +1.11%
FTSE 100 5,318.81 -1.34%
STOXX 50 2,136.84 -1.09%
DAX 6,337.62 -0.93%
Oil (WTI) 89.68 -1.19%
U.S. 10-year 1.690% -0.055
BAC:US 7.44 +4.06%
FB:US 28.84 -9.62%
  • Exchange: -
  • Sector: Consumer, Non-cyclical
  • Industry: Biotechnology
  • Sub-Industry: Medical-Biomedical/Gene

Pharmasset Inc

VRUS:US

Acquired

As of 01/17/2012.

Pharmasset Inc (VRUS:US) was acquired by GILD:US


Company Profile

Pharmasset, Inc. is a pharmaceutical company. The Company develops oral therapeutics for the human immunodeficiency virus (HIV), hepatitis B (HBV), and hepatitis C (HCV).

Advertisement